Tirzepatide 60mg

Description

Tirzepatide 60mg research peptide

Tirzepatide is a synthetic peptide used in laboratory investigation of dual GIP and GLP-1 receptor pharmacology. PubChem records the molecular formula as C225H348N48O68 and molecular weight as approximately 4813 g/mol. This 60mg format is intended for controlled receptor, signaling, and analytical research workflows.

Research applications

• Dual GIP/GLP-1 receptor binding and activation assays
• Comparative incretin-pathway and metabolic-signaling models
• Peptide identity, purity, stability, and analytical method development

Product specifications

• Label amount: 60mg
• Molecular formula: C225H348N48O68
• Molecular weight: approximately 4813 g/mol
• Documentation: review the lot-specific COA when available

Research use only. Not intended for human or animal use, consumption, administration, diagnosis, treatment, weight management, or any medical application.

Experimental design and evidence boundaries

Published observations involving this material may depend on model system, concentration, exposure interval, assay platform, controls, and material provenance. Results from biochemical, cellular, ex-vivo, or animal models should not be represented as evidence of human safety or clinical effectiveness. Researchers should document lot identity, solvent system, assay conditions, reference standards, and acceptance criteria before comparing results across studies.

Identity, purity, and traceability

Identity and purity should be evaluated against the lot-specific certificate of analysis and any available chromatographic or mass-spectrometric documentation. The product label and current COA control over general website information when specifications differ by lot.